Literature DB >> 34158330

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits associated with parvovirus B19.

Rosalba Santana de Roberts1, Ibrahim Batal2, Amr Aljareh1, Belinda Jim3.   

Abstract

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is included in the group of dysproteinaemias causing renal disease. Only a minority of cases are associated with a haematological malignancy. Two cases have been linked to acute parvovirus B19 infections. We report a 36-year-old African-American woman who presented with renal dysfunction, proteinuria, haematuria and a kidney biopsy reported as PGNMID with IgG3-kappa deposits. Her evaluation for a haematological malignancy was unrevealing. Her parvovirus IgM and IgG levels were positive. The patient was initially treated with an ACE inhibitor and spontaneously remitted with minimal proteinuria after 1 month. Repeat parvovirus B19 serologies 6 months later showed persistent IgG and DNA by PCR positivity but IgM negativity. Given the clinical scenario, we believe that her PGNMID was induced by acute parvovirus B19 infection, which appeared to resolve once her acute infection abated. In this report, we describe our latest understanding of PGNMID. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs: infectious diseases; immunology; nephrotic syndrome; proteinurea

Mesh:

Substances:

Year:  2021        PMID: 34158330     DOI: 10.1136/bcr-2021-243061

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.

Authors:  Mengyao Liu; Xiaojuan Yu; Suxia Wang; Aibo Qin; Fude Zhou; Minghui Zhao
Journal:  J Nephrol       Date:  2022-04-23       Impact factor: 3.902

2.  Proliferative Glomerulonephritis With Monotypic Immunoglobulin Deposits: An Unusual Presentation in the Setting of Multiple Inciting Events Including COVID-19 Vaccination.

Authors:  Jagan Mohan Rao Vanjarapu; Jose Iglesias; Rumana Ahmed; Pratiksha Singh; Gabrielle Gerbino; Michael Barry Stokes
Journal:  Cureus       Date:  2022-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.